Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: J Surg Oncol. 2017 Jun 1;116(3):351–358. doi: 10.1002/jso.24674

Figure 2.

Figure 2

Adjuvant treatments for patients with T1-T2 OPSCC undergoing primary surgical approach, for whom ECS and margin status are known. N= 4833 including 1528 (32%) receiving surgery alone, 1185 (25%) receiving surgery and post-operative radiation (RT), and 2120 (44%) receiving postoperative CRT.